Search Results - "Garrido, Noemi"
-
1
An Unusual Case of Allergic Reaction to Anakinra in a Patient with Tumor Necrosis Factor Receptor-1 Associated Periodic Syndrome (TRAPS) and Subsequent Canakinumab Treatment
Published in European journal of case reports in internal medicine (29-07-2020)“…Tumor necrosis factor (TNF) receptor-associated periodic syndrome (TRAPS) is a rare hereditary systemic autoinflammatory disease (SAID). Treatment is based on…”
Get full text
Journal Article -
2
Validity, reproducibility, and responsiveness of a twelve‐joint simplified power doppler ultrasonographic assessment of joint inflammation in rheumatoid arthritis
Published in Arthritis and rheumatism (15-04-2008)“…Objective To investigate the validity, reproducibility, and responsiveness of a simplified power Doppler ultrasound (PDUS) assessment of joint inflammation…”
Get full text
Journal Article -
3
Management of particular clinical situations in psoriatic arthritis: an expert’s recommendation document based on systematic literature review and extended Delphi process
Published in Rheumatology international (01-09-2021)“…To establish practical recommendations for the management of patients with psoriatic arthritis (PsA) with particular clinical situations that might lead to…”
Get full text
Journal Article -
4
Extension of the RENACER Study: 12-Month Efficacy, Safety and Certolizumab PEGol Survival in 501 Rheumatoid Arthritis Patients
Published in Reumatología clinica (01-01-2021)Get full text
Journal Article -
5
How elderly rheumatoid arthritis patients respond at one year of treatment with certolizumab pegol
Published in Rheumatology international (01-02-2019)Get full text
Journal Article -
6
RENACER study: Assessment of 12-month efficacy and safety of 168 certolizumab PEGol rheumatoid arthritis-treated patients from a Spanish multicenter national database
Published in Modern rheumatology (03-05-2016)“…Objective: To assess effectiveness and safety of certolizumab PEGol (CZP) in rheumatoid arthritis (RA) patients after 12 months of treatment and to detect…”
Get full text
Journal Article -
7
Extension of the RENACER Study: 12-Month Efficacy, Safety and Certolizumab PEGol Survival in 501 Rheumatoid Arthritis Patients
Published in Reumatología clinica (Barcelona) (01-01-2021)Get full text
Journal Article